 | • レポートコード：MRC2203A747 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界の麻酔ガス市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（麻酔ガス、気化器装置）分析、エンドユーザー別（病院、外来手術センター）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の麻酔ガス市場規模：製品別（麻酔ガス、気化器装置） ・世界の麻酔ガス市場規模：エンドユーザー別（病院、外来手術センター） ・世界の麻酔ガス市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（AbbVie Inc.、Baxter International Inc.、Dragerwerk AG & Co. KGaA、...） ・市場機会・将来の傾向 |
The Anesthesia Gases market studied was valued at USD 1,588.07 million in 2018, and is expected to reach USD 1,969.18 million by 2024, with an anticipated CAGR of 3.65%, during the forecast period (2019-2024).
The major factors attributing to the growth of the anesthesia gases market are increasing geriatric population prone to chronic diseases, and increasing number of emergency cases. The increasing number of emergency cases, including accident cases and emergency labor, among others, is driving the growth of the market studied. Anesthetic gases are commonly used for accident care, as inducing anesthesia through the intravenous route of administration is not an easy task in ambulatory settings. In emergency labors, rapid sequence induction of general anesthesia is performed via tracheal intubation. The number of emergency visits has increased over the years. According to an article by Hooker EA et al. published in the Journal of Emergency Medicine 2019, between 2010 and 2014, the number of US emergency department visits increased from 128.9 million to 137.8 million. As anesthetic gases are majorly used in emergency cases, increasing number of emergency cases is expected to help this market grow in the forecast period.
Key Market Trends
Isoflurane Gas is Expected to Grow Faster in the Anesthesia Gases Segment
Isoflurane, sold under the trade name Forane, among other names, is a general anesthetic drug. Isoflurane was approved for medical use in the United States in 1979. The drug was manufactured by Baxter International in 1986 as an inhalant. In 1996, the company started manufacturing in the liquid form. The companies that are providing isoflurane in the developed markets include the AbbVie, Halocarbon Laboratories and Technilab Pharma Inc. Hospira Inc. and Piramal Health are also involved in the manufacture and sales of isoflurane generics. The developed countries have a high usage rate of this drug, but in developing countries, the adoption of isoflurane is less compared to that of the developed countries. However, countries like India have a few local players, such as GNH India, that are providing isoflurane under the trade name Forane. However, the marketing authorization holder of the drug is Abbott Laboratories, India. Considering all the companies that are involved in manufacturing or marketing of isoflurane, along with the benefits provided by the same, it is estimated that the market is likely to experience rapid growth over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. This is due to the rising geriatric population. In North America region, the United States holds the largest market share. The United States anesthesia gases market is one of the largest regional market in the world and the country has witnessed a rapid increase in the number of chronic diseases such as cardiovascular diseases, and different types of cancers which is accelerating the number of surgeries in the country. Furthermore, factors such as obesity & lifestyle changes are contributing to the growth of the market studied.
Competitive Landscape
The Anesthesia gases market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising aging population and the increasing number of emergency cases, few other smaller players are also expected to enter into the market in the coming years. Some of the major players of the market are AbbVie Inc., Baxter, Drägerwerk AG & Co. KGaA, Fresenius SE & Co. KGaA and GE Healthcare are among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Geriatric Population Prone To Chronic Diseases
4.2.2 Increasing Number of Emergency Cases
4.3 Market Restraints
4.3.1 Increasing Generic Anesthesia Usage
4.3.2 Side Effects of Anesthesia Gases
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 By Anesthesia Gases
5.1.1.1 Desflurane
5.1.1.2 Sevoflurane
5.1.1.3 Isoflurane
5.1.1.4 Nitrous Oxide
5.1.1.5 Other Anesthesia Gases
5.1.2 Vaporizer Devices
5.2 By End User
5.2.1 Hospitals
5.2.2 Ambulatory Surgery Centers
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AbbVie Inc.
6.1.2 Baxter International Inc.
6.1.3 Dragerwerk AG & Co. KGaA
6.1.4 Fresenius SE & Co. KGaA
6.1.5 GE Healthcare
6.1.6 Mindray Medical International Limited
6.1.7 Piramal Enterprise Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS